This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Living With Chronic Myelogenous Leukemia in Rural Communities: Exploring Factors Related to Tyrosine Kinase Inhibitors Adherence With a Mixed Methods Approach

Link
View Resource
Description
Presents a study on the use of tyrosine kinase inhibitor (TKI), which improves chronic myeloid leukemia (CML) outcomes, among rural CML patients. Bases findings on semi-structured interviews detailing side effects, perceived stress, and ability to self-manage chronic conditions, among other factors.
Author(s)
Jingxi Sheng, Sue P. Heiney, Karen E. Wickersham, et al.
Citation
Journal of Rural Health, 41(2), e70028
Date
04/2025
Tagged as
Cancer · Health literacy · Population health · Specialty care · Statistics and data